335 related articles for article (PubMed ID: 20855524)
1. Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.
Revenko AS; Kalashnikova EV; Gemo AT; Zou JX; Chen HW
Mol Cell Biol; 2010 Nov; 30(22):5260-72. PubMed ID: 20855524
[TBL] [Abstract][Full Text] [Related]
2. Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.
Duan Z; Zou JX; Yang P; Wang Y; Borowsky AD; Gao AC; Chen HW
Prostate; 2013 Apr; 73(5):455-66. PubMed ID: 23038103
[TBL] [Abstract][Full Text] [Related]
3. Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.
Zou JX; Duan Z; Wang J; Sokolov A; Xu J; Chen CZ; Li JJ; Chen HW
Mol Cancer Res; 2014 Apr; 12(4):539-49. PubMed ID: 24391143
[TBL] [Abstract][Full Text] [Related]
4. ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.
Zou JX; Revenko AS; Li LB; Gemo AT; Chen HW
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18067-72. PubMed ID: 17998543
[TBL] [Abstract][Full Text] [Related]
5. Deregulated E2F and the AAA+ coregulator ANCCA drive proto-oncogene ACTR/AIB1 overexpression in breast cancer.
Hsia EY; Kalashnikova EV; Revenko AS; Zou JX; Borowsky AD; Chen HW
Mol Cancer Res; 2010 Feb; 8(2):183-93. PubMed ID: 20124470
[TBL] [Abstract][Full Text] [Related]
6. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.
Kalashnikova EV; Revenko AS; Gemo AT; Andrews NP; Tepper CG; Zou JX; Cardiff RD; Borowsky AD; Chen HW
Cancer Res; 2010 Nov; 70(22):9402-12. PubMed ID: 20864510
[TBL] [Abstract][Full Text] [Related]
7. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases.
Tyagi S; Chabes AL; Wysocka J; Herr W
Mol Cell; 2007 Jul; 27(1):107-19. PubMed ID: 17612494
[TBL] [Abstract][Full Text] [Related]
8. Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription.
Chang PY; Hom RA; Musselman CA; Zhu L; Kuo A; Gozani O; Kutateladze TG; Cleary ML
J Mol Biol; 2010 Jul; 400(2):137-44. PubMed ID: 20452361
[TBL] [Abstract][Full Text] [Related]
9. Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNA‑damaging chemotherapy agents and radiation.
Duan Z; Andrews NP; Chen CZ; Fan M; Wang J; Shen J; Li JJ; Chen HW
Oncol Rep; 2020 Jan; 43(1):318-327. PubMed ID: 31789405
[TBL] [Abstract][Full Text] [Related]
10. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance.
Louie MC; Zou JX; Rabinovich A; Chen HW
Mol Cell Biol; 2004 Jun; 24(12):5157-71. PubMed ID: 15169882
[TBL] [Abstract][Full Text] [Related]
11. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
[TBL] [Abstract][Full Text] [Related]
12. Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.
Zou JX; Guo L; Revenko AS; Tepper CG; Gemo AT; Kung HJ; Chen HW
Cancer Res; 2009 Apr; 69(8):3339-46. PubMed ID: 19318566
[TBL] [Abstract][Full Text] [Related]
13. A reconfigured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit.
Blobel GA; Kadauke S; Wang E; Lau AW; Zuber J; Chou MM; Vakoc CR
Mol Cell; 2009 Dec; 36(6):970-83. PubMed ID: 20064463
[TBL] [Abstract][Full Text] [Related]
14. A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.
Kim JY; Banerjee T; Vinckevicius A; Luo Q; Parker JB; Baker MR; Radhakrishnan I; Wei JJ; Barish GD; Chakravarti D
Mol Cell; 2014 May; 54(4):613-25. PubMed ID: 24793694
[TBL] [Abstract][Full Text] [Related]
15. Mixed lineage leukemia 5 (MLL5) protein regulates cell cycle progression and E2F1-responsive gene expression via association with host cell factor-1 (HCF-1).
Zhou P; Wang Z; Yuan X; Zhou C; Liu L; Wan X; Zhang F; Ding X; Wang C; Xiong S; Wang Z; Yuan J; Li Q; Zhang Y
J Biol Chem; 2013 Jun; 288(24):17532-43. PubMed ID: 23629655
[TBL] [Abstract][Full Text] [Related]
16. Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.
Yang P; Guo L; Duan ZJ; Tepper CG; Xue L; Chen X; Kung HJ; Gao AC; Zou JX; Chen HW
Mol Cell Biol; 2012 Aug; 32(15):3121-31. PubMed ID: 22645312
[TBL] [Abstract][Full Text] [Related]
17. E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1.
Taubert S; Gorrini C; Frank SR; Parisi T; Fuchs M; Chan HM; Livingston DM; Amati B
Mol Cell Biol; 2004 May; 24(10):4546-56. PubMed ID: 15121871
[TBL] [Abstract][Full Text] [Related]
18. ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.
Ciró M; Prosperini E; Quarto M; Grazini U; Walfridsson J; McBlane F; Nucifero P; Pacchiana G; Capra M; Christensen J; Helin K
Cancer Res; 2009 Nov; 69(21):8491-8. PubMed ID: 19843847
[TBL] [Abstract][Full Text] [Related]
19. Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.
Zhou C; Zhang Y; Dai J; Zhou M; Liu M; Wang Y; Chen XZ; Tang J
Sci Rep; 2016 Feb; 6():22066. PubMed ID: 26902498
[TBL] [Abstract][Full Text] [Related]
20. The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes.
Langini C; Caflisch A; Vitalis A
J Biol Chem; 2017 Oct; 292(40):16734-16745. PubMed ID: 28798233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
